Cargando…

The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is the most common cancer in children. While survival rates for ALL have improved, central nervous system (CNS) relapse remains a significant cause of treatment failure and treatment-related morbidity. Accordingly, there is a need to identify more efficacious and l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gossai, Nathan P., Gordon, Peter M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405081/ https://www.ncbi.nlm.nih.gov/pubmed/28491865 http://dx.doi.org/10.3389/fped.2017.00090

Ejemplares similares

Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia
por: Burke, Michael J., et al.
Publicado: (2014)

Chemotherapy-Induced Oxidative Stress in Pediatric Acute Lymphoblastic Leukemia
por: Chaudhary, Preety, et al.
Publicado: (2023)

Assessment of the Prevalence of Infections in Pediatric Patients With Acute Lymphoblastic Leukemia
por: Nair, Arun, et al.
Publicado: (2023)

Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia: An Analysis of Day-One Versus Day-Eight Lumbar Punctures in Remission Induction Therapy
por: Arshad, Uzma, et al.
Publicado: (2021)

Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia
por: Zhang, JinFang, et al.
Publicado: (2022)

Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wang, Han, et al.
Publicado: (2022)

Association of the clinical profile and overall survival of pediatric patients with acute lymphoblastic leukemia
por: Correa, Bruno Terra, et al.
Publicado: (2023)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

Isolated Central Nervous System Relapse of Acute Lymphoblastic Leukemia
por: Sung, Sang-Hyun, et al.
Publicado: (2014)

Thrombosis Complications in Pediatric Acute Lymphoblastic Leukemia: Risk Factors, Management, and Prevention: Is There Any Role for Pharmacologic Prophylaxis?
por: Rodriguez, Vilmarie
Publicado: (2022)

Testicular relapse of acute lymphoblastic leukemia()
por: Carolan, Alexandra, et al.
Publicado: (2023)

Targeted Treatment and Immunotherapy in High-risk and Relapsed/Refractory Pediatric Acute Lymphoblastic Leukemia
por: Graiqevci-Uka, Violeta, et al.
Publicado: (2022)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021)

Pediatric Leukemia From an Orthopedic Perspective: A Case of Acute Lymphoblastic Leukemia Initially Managed as Septic Hip With Osteomyelitis
por: Gkoudina, Antigoni, et al.
Publicado: (2022)

The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
por: Marrapodi, Maria Maddalena, et al.
Publicado: (2022)

Synthesized evidence for childhood acute lymphoblastic leukemia
por: Onyije, Felix M., et al.
Publicado: (2023)

Pediatric Central Nervous System Tumors: State-of-the-Art and Debated Aspects
por: Foster, Mitchell T., et al.
Publicado: (2018)

Central nervous system therapy in acute lymphoblastic leukemia: no more, no less
por: Rives, Susana
Publicado: (2023)

The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
por: Sheng, Xia, et al.
Publicado: (2014)

Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
por: Wu, Ying, et al.
Publicado: (2022)

Metabolomics of the Tumor Microenvironment in Pediatric Acute Lymphoblastic Leukemia
por: Tiziani, Stefano, et al.
Publicado: (2013)

Editorial: Pediatric Central Nervous System Tumors: State-of-the-Art and Debated Aspects
por: Carai, Andrea, et al.
Publicado: (2020)

Case Report: Trichosporon japonicum Fungemia in a Pediatric Patient With Refractory Acute B Cell Lymphoblastic Leukemia
por: Albitar-Nehme, Sami, et al.
Publicado: (2022)

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
por: Mengxuan, Shang, et al.
Publicado: (2022)

Corrigendum: Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
por: Wu, Ying, et al.
Publicado: (2022)

Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
por: Zhan, Min, et al.
Publicado: (2023)

Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes
por: Anastasopoulou, Stavroula, et al.
Publicado: (2022)

Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions
por: Thastrup, Maria, et al.
Publicado: (2022)

Integrins and the Metastasis-like Dissemination of Acute Lymphoblastic Leukemia to the Central Nervous System
por: Modvig, Signe, et al.
Publicado: (2023)

Prevalence of Osteopathologies in Children and Adolescents After Diagnosis of Acute Lymphoblastic Leukemia
por: Schündeln, Michael M., et al.
Publicado: (2020)

Malignant hypercalcemia as the debut of acute lymphoblastic leukemia in a pediatric patient—a diagnostic and therapeutic approach: Case report
por: Bonilla Gonzalez, Carolina, et al.
Publicado: (2022)

A damage-associated molecular patterns-related gene signature for the prediction of prognosis and immune microenvironment in children stage III acute lymphoblastic leukemia
por: Zhao, Feng, et al.
Publicado: (2022)

The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) – Mechanisms and Opportunities
por: Bernt, Kathrin M., et al.
Publicado: (2016)

Pancytopenia – (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia
por: Raja, Shruti, et al.
Publicado: (2015)

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

Bacteriological Spectrum and Antibiotic Susceptibility on Blood Culture in Newly Diagnosed Pediatric Patients With Acute Lymphoblastic Leukemia During the Induction Phase
por: Fawad, Usman
Publicado: (2022)

Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase
por: Tang, Elizabeth R., et al.
Publicado: (2018)

Relapsed Childhood Acute Lymphoblastic Leukemia: A Single-Institution Experience
por: Tuong, Pham Nguyen, et al.
Publicado: (2020)

Molecular Analysis of Central Nervous System Disease Spectrum in Childhood Acute Lymphoblastic Leukemia
por: Hicks, Chindo, et al.
Publicado: (2016)

MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia
por: Egyed, Bálint, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_53rjepr1oo98ffhd8fpot1ki6s